- October 19, 2021
- Comments: 0
- Posted by: admin
Spas & Beauty Salons Market Research Report by Type (Beauty Salon, Merchandise Sales, and Spa), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2026 – Cumulative Impact of COVID-19
New York, July 08, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "Spas & Beauty Salons Market Research Report by Type, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19" – https://www.reportlinker.com/p06088005/?utm_source=GNW
The Global Spas & Beauty Salons Market size was estimated at USD 143.82 Billion in 2020 and expected to reach USD 151.53 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 5.69% from 2020 to 2026 to reach USD 200.55 Billion by 2026.
Market Statistics:
The report provides market sizing and forecast across five major currencies – USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Spas & Beauty Salons to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Spas & Beauty Salons Market was studied across Beauty Salon, Merchandise Sales, and Spa. The Beauty Salon is further studied across Facials & Skin Care Salon, Full-Service Salon, Hair Salon, Nail Salon, Tanning Salon, and Waxing Salon. The Spa is further studied across Club Spas, Day Spas, Destination Spas, Medical Spas, Mineral Springs Spas, and Resort & Hotel Spas.
Based on Geography, the Spas & Beauty Salons Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Spas & Beauty Salons Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Spas & Beauty Salons Market, including Bradley & Diegel Salon, Butterfly Studio Salon, Chris Chase Salon, John Barrett Salon, Madeline Wade, Metodo Rossano Ferretti Salon, Metropolis Salon, Paul Labrecque Salon & Spa, Robert James Salon & Spa, Rossano Ferretti, Salon U, Takamichi Hair, The Roose Parlour & Spa, and VASKEN SALON.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Spas & Beauty Salons Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spas & Beauty Salons Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spas & Beauty Salons Market?
4. What is the competitive strategic window for opportunities in the Global Spas & Beauty Salons Market?
5. What are the technology trends and regulatory frameworks in the Global Spas & Beauty Salons Market?
6. What is the market share of the leading vendors in the Global Spas & Beauty Salons Market?
7. What modes and strategic moves are considered suitable for entering the Global Spas & Beauty Salons Market?
Read the full report: https://www.reportlinker.com/p06088005/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Yahoo Finance's Jennifer Schonberger breaks down what to know about the Bitcoin futures ETF set to trade on the NYSE.
OUTSIDE THE BOX It’s embarrassing to admit in a public forum that I failed at retirement. But I’m doing so — because I think people can learn from me, and thereby avoid making the same mistakes. I spent my entire 38-year career in the banking industry.
Although the computer chip shortage wrecked third-quarter auto sales by causing third quarter auto sales to tumble, the market still finds an investment in Ford (NYSE: F) to be intriguing. Ford's sales for the period were hurt along with most everyone else's, but it was actually able to beat expectations and management says sales improved as the quarter progressed. Because the automaker also continued its dominance in the truck market and sales of its electric vehicles are revving up, it's no wonder everyone is talking about Ford's stock.
After slipping through September, markets have been trending up again in October. One possible reason: better-than-expected results from the Q3 earnings reports so far. With results in from 41 companies listed on the S&P 500, aggregate earnings are up more than 40% year-over-year. These solid results come even as revenues are down 13% yoy. Of the companies that have reported so far, 85% beat the anticipated EPS, while 70% beat on revenues. With these results, it should come as no surprise to see
Ma, who has largely been out of public view since a speech last year in which he publicly criticized China's regulatory system, is in Spain for a study tour on agriculture and technology related to environmental issues, the report said, citing a source familiar with Ma's schedule. He was in Hong Kong spending "private time" with this family before flying to Europe, according to SCMP, which is owned by Alibaba.
In the investment world, Cathie Wood has garnered increasing attention for her successes in recent years. Holdings such as Nano Dimension (NASDAQ: NNDM), Teladoc Health (NYSE: TDOC), and Twitter (NYSE: TWTR) have the potential to boost those returns further. Nano Dimension stands out in the 3D printing world for its unique capabilities — its printers can make circuit boards.
Just when the stock of edge network software specialist Cloudflare (NYSE: NET) seemed like it couldn't go any higher in the near term, it did. The growth stock soared almost 8% on Monday, giving shares a 57% gain month to date. Investors cheered as the company announced a partnership with Microsoft's Bing (NASDAQ: MSFT) and other search engines to make search results more timely.
If you have excess cash not required to pay bills, pay down debt, or bolster an emergency fund, consider picking up stock in Upstart (NASDAQ: UPST), Zillow Group (NASDAQ: ZG) (NASDAQ: Z), and MongoDB (NASDAQ: MDB) this October. By leveraging the power of several cutting-edge technologies, including artificial intelligence, machine learning, predictive modeling, and big data, Upstart can track over 1,600 data variables across millions of transactions to determine a person's creditworthiness. The success of the company is apparent considering that 25 banks and credit unions were on the Upstart platform at end of the second quarter (ending June 30), more than double the number at the end of September 2020.
The company released a discouraging business update after market hours on Friday, and its stock took it on the chin the following trading day. In that update, Medtronic said that a clinical trial of its Symplicity Renal Denervation System to lower blood pressure in hypertension patients will continue for an unspecified length of time. In Medtronic's words, the monitoring board "has recommended that clinical trial enrollment continue as planned, until the full, predefined sample size is reached."
Oil prices continue to march higher. Brent, the global oil benchmark, recently touched $85 a barrel, while WTI, the U.S. oil price benchmark, is just a couple of dollars behind. Crude prices are pushing levels not seen since 2014.
Yahoo Finance's Brian Cheung breaks down the major takeaways from the SEC report.
As the fears of the memory chip price declines start to materialize, the latest slump of Micron Technology (NASDAQ: MU) completely erased the yearly gains. While short-term headwinds shouldn't be a reason to "panic-sell, "prospective buyers should carefully evaluate upsides vs. downsides in their investment time frame.
Mr. Wonderful is calling for a Bitcoin boom. But he hasn't forgotten about dividends.
In this article, we will be taking a look at the 12 best stocks that pay monthly dividends. To skip our detailed analysis of dividend investing, you can go directly to see the 5 Best Stocks That Pay Monthly Dividends. Dividend investing is a strategy that has long been integrated into investor circles, particularly by […]
It's looking like COVID-19 boosters will go three-for-three in winning authorizations. An advisory committee to the U.S. Food and Drug Administration (FDA) voted unanimously last week in support of boosters for Moderna's (NASDAQ: MRNA) COVID-19 vaccine and for Johnson & Johnson's (NYSE: JNJ) vaccine. The FDA has already granted Emergency Use Authorization (EUA) to boosters for the COVID-19 vaccine marketed by Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX).
R "Ray" Wang, Constellation Research Principal Analyst & Founder, joins Yahoo Finance to discuss the latest product releases from Apple ahead of the holiday season.
ARK Invest founder Cathie Wood doesn't mind going against the grain. Here are three beaten-down stocks Wood is buying that Wall Street thinks will skyrocket. Shares of Arcturus Therapeutics (NASDAQ: ARCT) are still more than 60% below the highs from December despite a partial rebound this summer.
Shares of EverQuote, Inc. (EVER) declined 5.4% in extended trade on Monday after the company announced lower preliminary revenue for the third quarter of 2021 (ended September 30, 2021). The company operates as an online insurance marketplace, which connects consumers with insurance providers. (See EverQuote stock charts on TipRanks) The company expects to report third-quarter revenue in the range of $106.5 million to $107.5 million, down from $109 million to $111 million guided previously. The
The company applied in April for Food and Drug Administration approval to sell the new product. Now that process could take a bit more time.
In this article, we will be taking a look at the 10 healthcare stocks to buy according to billionaire Noam Gottesman’s GLG Partners. If you want to skip our detailed analysis about the fund and its owner, go directly to the 5 Healthcare Stocks to Buy According to Billionaire Noam Gottesman’s GLG Partners. Noam Gottesman […]
